Company Overview and News
HOUSTON/CALGARY, Alberta, May 24 (Reuters) - Pipeline bottlenecks have vexed North American oil producers this year, but for companies making a little-known additive called drag-reducing agent (DRA), they have provided a veritable windfall.
NEW YORK (Reuters) - General Electric Co (GE.N) Chief Executive John Flannery said he is planning for the market for heavy duty gas power turbines to remain weak through 2020, and sees no profit growth at the large GE power business this year, according to a presentation he was due to make on Wednesday.
It has been about a month since the last earnings report for Halliburton Company (HAL - Free Report) . Shares have added about 4.5% in that time frame.
It was a week where oil prices consolidated above $70-a-barrel and natural gas futures got a lift from growing cooling demand.
Natural gas stocks broke the 100 Bcf/d refill threshold, in spite of steady supply and vigorous demand lift.
As shares of General Electric Company (NYSE:GE) have plunged, the calls for a breakup have grown louder. Bulls see the true value of GE stock as clouded by issues at GE Capital and weakness in divisions such as Lighting and Transportation. With two still-growing businesses — Aviation and Healthcare — plus a 62.5% stake in Baker Hughes a GE Co (NYSE:BHGE), optimists argue there has to be some value in General Electric stock, particularly after a 50%-plus decline from 2016 highs.
In the week ending May 18, the oil rig count was unchanged from the previous week at 844—the highest level in more than three years. US crude oil prices lead the rig count by three to six months. The following graph illustrates the pattern.
General Electric is moving to reduce its size and simplify its business, and selling off its railroad business is just one more step on that path.
General Electric Company (NYSE:GE) is finally doing what analysts expected, even demanded it do after John Flannery became CEO last year.
Baker Hughes, a GE Company (BHGE), released its US crude oil and natural gas rig count report on May 18. Baker Hughes reported that US crude oil rigs were flat at 844 on May 11–18—the highest level since March 13, 2015. The rigs have also risen by 132 or ~18.5% from a year ago.
In its weekly release, Baker Hughes (BHGE - Free Report) , a GE company, reported an increase in rig count in the United States.
Oil advanced near $72 a barrel as an economic truce between the U.S. and China eased fears of a trade war, and before a meeting on crude prices between the ministers of top producers Russia and Saudi Arabia.
Aviation stocks on Monday took a beating on the back of rising oil prices, with maximum fall seen in SpiceJet, which cracked 12 percent.
It has been about a month since the last earnings report for General Electric Company (GE - Free Report) . Shares have added about 7.4% in that time frame.
SINGAPORE: Oil advanced near $72 a barrel as an economic truce between the U.S. and China eased fears of a trade war, and before a meeting on crude prices between the ministers of top producers Russia and Saudi Arabia. Futures in New York rose as much as 0.9 percent. U.S. Treasury Secretary Steven Mnuchin said Sunday the two nations are “putting the trade war on hold” as they work on a framework to balance trade.
22h - Asif
Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...
22h - Asif
Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
as of ET